CEN/TC 140
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 81454 | prEN ISO 25379-1 | In vitro diagnostic Next Generation Sequencing (NGS) workflows -- Part 1: Part 1: Human DNA examination | Izstrādē |
| 62240 | - | Quality assurance of POCT results - Assessment criteria for comparison measurement and implementation | Izstrādē |
| 61686 | EN ISO 20186-3:2019 | Molecular in-vitro diagnostic examinations - Specifications for pre-examination processes for venous whole blood - Part 3: Isolated circulating cell free DNA from plasma (ISO 20186-3:2019) | Izstrādē |
| 60768 | - | Haematology - Determination of the concentration of total haemoglobin in blood - Reference methods | Izstrādē |
| 60919 | prEN ISO 23640 rev | In vitro diagnostic medical devices - Evaluation of stability of in vitro diagnostic reagents | Izstrādē |
| 64589 | - | Molecular in vitro diagnostic examinations - Specifications for preexamination processes for saliva - Isolated DNA | Izstrādē |
| 77416 | prCEN ISO/TS 18701 | Molecular in vitro diagnostic examinations - Specificationsfor pre-examination processes for human specimens - Isolated microbiome DNA | Izstrādē |
| 64279 | EN ISO 22367:2020 | Medical laboratories - Application of risk management to medical laboratories (ISO 22367:2020) | Izstrādē |
| 39676 | - | Molecular in-vitro diagnostic examinations - Specifications for pre-examination processes for selected types of sample | Izstrādē |
| 70355 | EN ISO 20776-2:2022 | Clinical laboratory testing and in vitro diagnostic test systems - Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices - Part 2: Evaluation of performance of antimicrobial susceptibility test devices against reference broth micro-dilution (ISO 20776-2:2021) | Izstrādē |
Displaying 51-60 of 272 results.